- Home
- JBDI vs BFRI Comparison
JBDI vs BFRI Comparison
Compare JBDI & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JBDI | BFRI |
|---|---|---|
| Founded | 1983 | 1997 |
| Country | Singapore | United States |
| Employees | 104 | 94 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 13.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JBDI | BFRI |
|---|---|---|
| Price | $0.57 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 6.9K | ★ 193.2K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $0.54 |
| 52 Week High | $2.28 | $1.19 |
Technical Indicators
Market Signals| Indicator | JBDI | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 30.24 |
| Support Level | $0.52 | $0.78 |
| Resistance Level | $0.63 | $0.94 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 9.73 | 18.06 |
Price Performance
Historical ComparisonAbout JBDI JBDI Holdings Limited Ordinary Shares
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. It's in the trading of reconditioned and recycling containers in Singapore and the Southeast Asia region. The company offers reconditioning and recycling drums, including open top drums, metal drums, plastic drums, plastic carboys, and intermediate bulk containers, as well as new drums, and collects waste drums and related products. It serves solvent, chemical, petroleum, and edible product oil industries.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.